1,264
Participants
Start Date
April 7, 2021
Primary Completion Date
September 5, 2024
Study Completion Date
January 26, 2026
Pembrolizumab/Vibostolimab
Coformulation of pembrolizumab (MK-3475) 200mg and vibostolimab (MK-7684) 200mg. Participants receive the coformulation by intravenous (IV) infusion every 3 weeks (Q3W) for up to 35 administrations (up to \~2 years).
Pembrolizumab
Participants receive 200 mg of pembrolizumab by intravenous (IV) infusion every 3 weeks (Q3W) for up to 35 administrations (up to \~2 years).
Semmelweis University-Pulmonológiai Klinika ( Site 1209), Budapest
East Avenue Medical Center-Department of Medicine ( Site 1605), Quezon City
Veterans Memorial Medical Center-Section of Oncology ( Site 1608), Quezon City
Országos Korányi Pulmonológiai Intézet-XIV. Tüdöbelgyógyászat ( Site 1204), Budapest
CARDINAL SANTOS MEDICAL CENTER ( Site 1606), San Juan City, Metro Manila
Wits Clinical Research-Wits Clinical Research Bara ( Site 0908), Soweto
Reformatus Pulmonologiai Centrum-Onkopulmonologiai Jarobeteg Centrum ( Site 1208), Törökbálint
Wits Clinical Research ( Site 0900), Johannesburg
Medical Oncology Centre of Rosebank ( Site 0906), Johannesburg
Sandton Oncology Medical Group (Pty) Ltd-Research ( Site 0902), Sandton
Mátrai Gyógyintézet ( Site 1214), Kékestető
Abraham Oncology ( Site 0907), Richards Bay
The Oncology Centre ( Site 0905), Durban
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház-Onkologiai Kozpont ( Site 1200), Szolnok
Békés Megyei Központi Kórház Pándy Kálmán Tagkórház-Megyei Onkológiai Centrum ( Site 1207), Gyula
Bacs-Kiskun Megyei Korhaz-Onkoradiologiai Kozpont ( Site 1201), Kecskemét
Cape Town Oncology Trials ( Site 0903), Cape Town
Zala Megyei Szent Rafael Kórház-Pulmonológia ( Site 1202), Zalaegerszeg
Petz Aladar Egyetemi Oktato Korhaz-Pulmonológia ( Site 1205), Győr
Zhytomyr Regional Oncology Center-Chemotherapy Department ( Site 1103), Zhytomyr
Gleneagles Penang Medical Center-Clinical Research Center (CRC) ( Site 1503), George Town
Memorial Sloan Kettering Cancer Center ( Site 0013), New York
Instituto de Oncologia ( Site 2300), Santo Domingo
CEMDOE - Centro Médico de Diabetes, Obesidad y Especialidades ( Site 2301), Santo Domingo
Chulalongkorn University ( Site 1802), Bangkok
Ramathibodi Clinical Research Centre ( Site 1801), Bangkok
National Cancer Center-Lung Cancer Center ( Site 1407), Goyang-si
Hospital Pulau Pinang ( Site 1501), George Town
Faculty of Medicine Siriraj Hospital ( Site 1800), Bangkok
Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022), Mineola
Seoul National University Bundang Hospital ( Site 1403), Seongnam
Chernihiv Medical Center of Modern Oncology-Clinical oncology and gynecology department ( Site 1113), Chernihiv
Human Science Research Trials ( Site 0406), Mexico City
Hospital Guillermo Almenara Irigoyen-Oncology ( Site 0508), Lima
IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0507), San Isidro
Clínica Internacional - Sede San Borja ( Site 0506), Lima
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS ( Site 0500), Lima
Hospital Militar Central Luis Arias Schereiber ( Site 0502), Lima
The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 1405), Suwon
Cherkasy Regional Oncology Dispensary ( Site 1110), Cherkassy
Fox Chase Cancer Center-Hematology/Oncology ( Site 0030), Philadelphia
Vinnytsia Regional Clinical Oncological Hospital ( Site 1102), Vinnytsia
Hospital Tengku Ampuan Afzan ( Site 1502), Kuantan
Chungbuk National University Hospital-Internal medicine ( Site 1406), Cheongju-si
Centro Oncologico de Chihuahua-Unidad de Investigacion Clinica ( Site 0402), Chihuahua City
Boca Raton Regional Hospital ( Site 0004), Boca Raton
Acıbadem Maslak Hastanesi ( Site 1008), Istanbul
Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1000), Istanbul
Erciyes University Medical Oncology Department ( Site 1007), Talas
Actualidad Basada en la Investigación del Cáncer-Lung Cancer ( Site 0411), Guadalajara
Municipal Non-profit Enterprise City Clinical Hospital #4 of Dnipro City Council ( Site 1100), Dnipro
MI Kryvyi Rih Oncology Dispensary of Dnipropetrovsk Regional-Chemotherapy department ( Site 1104), Kryvyi Rih
Samsun Medical Park Hastanesi-medical oncology ( Site 1005), Samsun
Centro de Investigacion Clinica Chapultepec ( Site 0400), Morelia
University Malaya Medical Centre ( Site 1504), Lembah Pantai
Institute of General and Emergency Surgery named after V.T. Zaitsev NAMS of Ukraine ( Site 1119), Kharkiv
Illinois Cancer Care ( Site 0026), Peoria
National Cancer Institute ( Site 1505), Putrajaya
Mercy Research - David C. Pratt Cancer Center ( Site 0025), St Louis
iCan Oncology Center Centro Medico AVE ( Site 0405), Monterrey
Mercy Research - Cancer and Hematology Center ( Site 0032), Springfield
Oaxaca Site Management Organization ( Site 0403), Oaxaca City
Oncolife LLC-day-stay department ( Site 1107), Zaporizhzhia
Hospital H+ Queretaro ( Site 0416), Querétaro City
Communal Non-Commercial Enterprise Prykarpatski Clinical Oncological Center of Ivano-Frankivsk Regio, Ivano-Frankivsk
Uzhgorod Central City Clinical Hospital-City oncology center ( Site 1120), Uzhhorod
Medical Care and Research SA de CV ( Site 0409), Mérida
Hanoi Oncology Hospital ( Site 2502), Hanoi
K Hospital - National Cancer Hospital ( Site 2506), Hanoi
National Lung Hospital-Oncology Department ( Site 2503), Hanoi
SC Medical Center Gral SRL ( Site 2203), Ploieşti
Cancer Hospital Chinese Academy of Medical Science-Oncology ( Site 2030), Beijing
Beijing Cancer hospital-intrathoratic deparmtment II ( Site 2001), Beijing
Beijing Cancer hospital-Thoracic Cancer Department A ( Site 2003), Beijing
Beijing Peking Union Medical College Hospital-pneumology department ( Site 2009), Beijing
Beijing Chest Hospital,Capital Medical University ( Site 2020), Beijing
All India Institute of Medical Sciences ( Site 2403), New Delhi
Rajiv Gandhi Cancer Institute And Research Centre ( Site 2400), New Delhi
Hadassah Medical-Oncology department ( Site 0814), Moscow
Central Clinical Hospital of the Presidential Administrative Department ( Site 0802), Moscow
Artemis hospital ( Site 2401), Gurugram
Jilin Cancer Hospital-oncology department ( Site 2000), Changchun
Moscow Regional Oncological Dispensary ( Site 0812), Balashikha
Harbin Medical University Cancer Hospital ( Site 2006), Harbin
GBUZ LOKB-Oncology department #1 ( Site 0804), Saint Petersburg
Scientific research institution of oncology named after N.N. Petrov-Thoracic oncology ( Site 0803), Saint Petersburg
Fudan University Shanghai Cancer Center ( Site 2032), Shanghai
"Centrul de Oncologie Sfântul Nectarie-Medical Oncology ( Site 2202)", Craiova
Northern Jiangsu People's Hospital-General Surgery Department ( Site 2016), Yangzhou
The First Affiliated Hospital of Anhui Medical University ( Site 2022), Hefei
Anhui Provincil Hospital South District-Respiratory Medicine Dept ( Site 2017), Hefei
LinYi Cancer Hospital ( Site 2034), Linyi
Hangzhou Cancer Hospital-Medical Oncology ( Site 2039), Hangzhou
Zhejiang Cancer Hospital-Breast Oncology ( Site 2008), Hangzhou
The Second Affiliated hospital of Zhejiang University school of medicine-Respiratory Medicine ( Site, Hangzhou
Taizhou Hospital of Zhejiang Province-Respiratory ( Site 2027), Linhai
The First Affiliated Hospital of Wenzhou Medical University-Respiratory department ( Site 2031), Wenzhou
Fujian Provincial Cancer Hospital-oncology department ( Site 2023), Fuzhou
Fuzhou General hospital of Nanjing Military Command-Oncology Department ( Site 2029), Fuzhou
Tata Memorial Hospital-Medical Oncology ( Site 2404), Mumbai
Cardiomed SRL Cluj-Napoca ( Site 2201), Cluj-Napoca
Chongqing Cancer Hospital-Medical Oncology ( Site 2028), Chongqing
Army Medical Center of People's Liberation Army-respiratory ( Site 2025), Chongqing
Xiangya Hospital Central South University-Respiratory -Asthma&COPD ( Site 2026), Changsha
Hunan Cancer Hospital-thoracic oncology II ( Site 2013), Changsha
Republican Clinical Oncology Dispensary ( Site 0805), Kazan'
Wuhan Union Hospital-Medical Oncology ( Site 2019), Wuhan
Henan Cancer Hospital ( Site 2015), Zhengzhou
Southern Medical University Nanfang Hospital-Depatrment of Respiratory and Critical Care Medicine (, Guangzhou
Nizhegorodsky Regional Oncology Dispensary, Branch #2-chemotherapy ( Site 0809), Nizhny Novgorod
West China Hospital Sichuan University-respiratory ( Site 2018), Chengdu
HCMC University Medical Center-Chemotherapy Department ( Site 2501), Ho Chi Minh City
Tang Du Hospital ( Site 2004), Xi'an
The First Affiliated Hospital of Xian Jiaotong University wa-Oncology ( Site 2012), Xi'an
Princess Margaret Hospital ( Site 1304), Lai Chi Kok
Bradford Hill Norte ( Site 0708), Antofagasta
IC La Serena Research ( Site 0710), La Serena
Clinica Universidad Catolica del Maule-Oncology ( Site 0703), Talca
James Lind Centro de Investigacion del Cancer ( Site 0711), Temuco
CIDO SpA-Oncology ( Site 0707), Temuco
Oncocentro Valdivia ( Site 0715), Valdivia
Clínica Puerto Montt ( Site 0713), Port Montt
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0712), Santiago
Orlandi Oncologia ( Site 0700), Santiago
FALP ( Site 0702), Santiago
Bradfordhill ( Site 0701), Santiago
Hospital São Carlos-Oncocentro Ce ( Site 0208), Fortaleza
Liga Norte Riograndense Contra o Câncer-Centro de Pesquisa Clínica ( Site 0201), Natal
ONCOSITE - Centro de Pesquisa Clinica em Oncologia ( Site 0206), Ijuí
Irmandade da Santa Casa de Misericórdia de Porto Alegre-Centro de Pesquisa Novos Tratamentos em Cân, Porto Alegre
CEPEN - Centro de Pesquisa e Ensino em Oncologia de Santa Catarina ( Site 0209), Florianópolis
Instituto Nacional de Câncer José Alencar Gomes da Silva - INCA ( Site 0204), Rio de Janeiro
ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO-Pesquisa Clinica ( Site 0200), São Paulo
Núcleo de Pesquisa Clínica da Rede São Camilo ( Site 0207), São Paulo
BC Cancer Victoria-Clinical Trials Unit ( Site 0107), Victoria
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0104), Hamilton
Kingston Health Sciences Centre-Kingston General Hospital Site ( Site 0102), Kingston
Lakeridge Health ( Site 0106), Oshawa
Centre Intégré de Santé et de Services Sociaux (CISSS) de La-Centre intégré de cancérologie de Lava, Laval
Linyi People's Hospital-Oncology ( Site 2035), Linyi
Queen Mary Hospital ( Site 1303), Hksar
Hong Kong United Oncology Centre ( Site 1302), Jordan
CELAN,S.A ( Site 0304), Guatemala City
Gastrosoluciones ( Site 0302), Guatemala City
INTEGRA Cancer Institute ( Site 0303), Guatemala City
Onco Go, S.A ( Site 0306), Guatemala City
Oncomedica-Guatemala ( Site 0301), Guatemala City
Grupo Medico Angeles ( Site 3007), Guatemala City
Hong Kong Integrated Oncology Centre ( Site 1301), Central
National Hospital Organization Nagoya Medical Center ( Site 1920), Nagoya
Fujita Health University ( Site 1906), Toyoake
Ehime University Hospital ( Site 1911), Tōon
Kurume University Hospital ( Site 1912), Kurume
Gunma Prefectural Cancer Center ( Site 1925), Otashi
National Hospital Organization Hokkaido Cancer Center ( Site 1923), Sapporo
Hyogo College of Medicine-Respiratory Medicine and Hematology ( Site 1922), Nishinomiya
Takarazuka City Hospital ( Site 1924), Takarazuka
Kanagawa Cardiovascular and Respiratory Center ( Site 1921), Yokohama
Kanagawa cancer center ( Site 1916), Yokohama
Sendai Kousei Hospital ( Site 1900), Sendai
Niigata Cancer Center Hospital ( Site 1904), Niigata
Kansai Medical University Hospital ( Site 1914), Hirakata
Kindai University Hospital- Osakasayama Campus ( Site 1907), Ōsaka-sayama
National Hospital Organization Kinki-chuo Chest Medical Center-Department of Thoracic Oncology ( Sit, Sakai
Osaka Medical and Pharmaceutical University Hospital ( Site 1908), Takatsuki
Shizuoka Cancer Center ( Site 1905), Nakatogari
Tochigi Cancer Center ( Site 1927), Utsunomiya
Chiba University Hospital-Medical Oncology ( Site 1926), Chiba
Okayama University Hospital ( Site 1913), Okayama
Osaka International Cancer Institute ( Site 1915), Osaka
Tokushima University Hospital ( Site 1917), Tokushima
Juntendo University Hospital ( Site 1902), Tokyo
Japanese Foundation for Cancer Research ( Site 1901), Tokyo
Wakayama Medical University Hospital ( Site 1910), Wakayama
Arké SMO S.A. de C.V. ( Site 0417), Mexico City
UNIDAD DE ONCOLOGIA HOSPITAL NACIONAL ADOLFO GUEVARA VELASCO ESSSALUD CUSCO ( Site 0504), Cusco
LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 0901), Pretoria
Seoul National University Hospital ( Site 1401), Seoul
Kangbuk Samsung Hospital ( Site 1409), Seoul
The Catholic University of Korea, Eunpyeong St. Mary's Hospital-Cancer center ( Site 1410), Seoul
Severance Hospital, Yonsei University Health System ( Site 1402), Seoul
Asan Medical Center ( Site 1400), Seoul
The Catholic Univ. of Korea Seoul St. Mary's Hospital-Medical Oncology ( Site 1408), Seoul
Hacettepe Universitesi-oncology hospital ( Site 1001), Ankara
Memorial Ankara Hastanesi-Medical Oncology ( Site 1002), Ankara
Gazi Universitesi-Oncology ( Site 1003), Ankara
National Cancer Institute ( Site 1114), Kyiv
Ho Chi Minh City Oncology Hospital - Tan Phu Ward ( Site 2505), Ho Chi Minh City
Merck Sharp & Dohme LLC
INDUSTRY